133 related articles for article (PubMed ID: 9880015)
1. Dendritic cells presenting equine herpesvirus-1 antigens induce protective anti-viral immunity.
Steinbach F; Borchers K; Ricciardi-Castagnoli P; Ludwig H; Stingl G; Elbe-Bürger A
J Gen Virol; 1998 Dec; 79 ( Pt 12)():3005-14. PubMed ID: 9880015
[TBL] [Abstract][Full Text] [Related]
2. Interactions between equine herpesvirus type 1 and equine herpesvirus type 4: T cell responses in a murine infection model.
Azmi M; Field HJ
J Gen Virol; 1993 Nov; 74 ( Pt 11)():2339-45. PubMed ID: 8245851
[TBL] [Abstract][Full Text] [Related]
3. Immunization with Attenuated Equine Herpesvirus 1 Strain KyA Induces Innate Immune Responses That Protect Mice from Lethal Challenge.
Kim SK; Shakya AK; O'Callaghan DJ
J Virol; 2016 Sep; 90(18):8090-104. PubMed ID: 27356904
[TBL] [Abstract][Full Text] [Related]
4. Role of T-cells, virus neutralising antibodies and complement-mediated antibody lysis in the immune response against equine herpesvirus type-1 (EHV-1) infection of C3H (H-2k) and BALB/c (H-2d) mice.
Alber DG; Greensill J; Killington RA; Stokes A
Res Vet Sci; 1995 Nov; 59(3):205-13. PubMed ID: 8588092
[TBL] [Abstract][Full Text] [Related]
5. Protective effects of intranasal immunization with recombinant glycoprotein d in pregnant BALB/c mice challenged with different strains of equine herpesvirus 1.
Fuentealba NA; Zanuzzi CN; Scrochi MR; Sguazza GH; Bravi ME; Cid de la Paz V; Corva SG; Portiansky EL; Gimeno EJ; Barbeito CG; Galosi CM
J Comp Pathol; 2014 Nov; 151(4):384-93. PubMed ID: 25124330
[TBL] [Abstract][Full Text] [Related]
6. Immunologic relationships between equine herpesvirus type 1 (equine abortion virus) and type 4 (equine rhinopneumonitis virus).
Fitzpatrick DR; Studdert MJ
Am J Vet Res; 1984 Oct; 45(10):1947-52. PubMed ID: 6208822
[TBL] [Abstract][Full Text] [Related]
7. Equine herpesvirus 1 mutants devoid of glycoprotein B or M are apathogenic for mice but induce protection against challenge infection.
Neubauer A; Beer M; Brandmüller C; Kaaden OR; Osterrieder N
Virology; 1997 Dec; 239(1):36-45. PubMed ID: 9426444
[TBL] [Abstract][Full Text] [Related]
8. Characterization of immune responses to baculovirus-expressed equine herpesvirus type 1 glycoproteins D and H in a murine model.
Tewari D; Whalley JM; Love DN; Field HJ
J Gen Virol; 1994 Jul; 75 ( Pt 7)():1735-41. PubMed ID: 8021602
[TBL] [Abstract][Full Text] [Related]
9. Cell-mediated antiviral response to equine herpesvirus type 1 demonstrated in a murine infection model by means of adoptive transfer of immune cells.
Azmi M; Field HJ
J Gen Virol; 1993 Feb; 74 ( Pt 2)():275-80. PubMed ID: 8381468
[TBL] [Abstract][Full Text] [Related]
10. A hamster model of equine herpesvirus type 1 (EHV-1) infection; passive protection by monoclonal antibodies to EHV-1 glycoproteins 13, 14 and 17/18.
Stokes A; Allen GP; Pullen LA; Murray PK
J Gen Virol; 1989 May; 70 ( Pt 5)():1173-83. PubMed ID: 2471805
[TBL] [Abstract][Full Text] [Related]
11. Serum antibody responses to equine herpesvirus 1 glycoprotein D in horses, pregnant mares and young foals.
Foote CE; Love DN; Gilkerson JR; Rota J; Trevor-Jones P; Ruitenberg KM; Wellington JE; Whalley JM
Vet Immunol Immunopathol; 2005 May; 105(1-2):47-57. PubMed ID: 15797474
[TBL] [Abstract][Full Text] [Related]
12. Potential of equine herpesvirus 1 as a vector for immunization.
Trapp S; von Einem J; Hofmann H; Köstler J; Wild J; Wagner R; Beer M; Osterrieder N
J Virol; 2005 May; 79(9):5445-54. PubMed ID: 15827159
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the efficacy of inactivated combination and modified-live virus vaccines against challenge infection with neuropathogenic equine herpesvirus type 1 (EHV-1).
Goodman LB; Wagner B; Flaminio MJ; Sussman KH; Metzger SM; Holland R; Osterrieder N
Vaccine; 2006 Apr; 24(17):3636-45. PubMed ID: 16513225
[TBL] [Abstract][Full Text] [Related]
14. Identification of equine herpesvirus-1 antigens recognized by cytotoxic T lymphocytes.
Soboll G; Whalley JM; Koen MT; Allen GP; Fraser DG; Macklin MD; Swain WF; Lunn DP
J Gen Virol; 2003 Oct; 84(Pt 10):2625-2634. PubMed ID: 13679596
[TBL] [Abstract][Full Text] [Related]
15. Protection against EHV-1 challenge infection in the murine model after vaccination with various formulations of recombinant glycoprotein gp14 (gB).
Osterrieder N; Wagner R; Brandmüller C; Schmidt P; Wolf H; Kaaden OR
Virology; 1995 Apr; 208(2):500-10. PubMed ID: 7747423
[TBL] [Abstract][Full Text] [Related]
16. Protective immunity against equine herpesvirus type-1 (EHV-1) infection in mice induced by recombinant EHV-1 gD.
Zhang Y; Smith PM; Tarbet EB; Osterrieder N; Jennings SR; O'Callaghan DJ
Virus Res; 1998 Jul; 56(1):11-24. PubMed ID: 9784062
[TBL] [Abstract][Full Text] [Related]
17. Quantitation of virus-specific classes of antibodies following immunization of mice with attenuated equine herpesvirus 1 and viral glycoprotein D.
Zhang Y; Smith PM; Jennings SR; O'Callaghan DJ
Virology; 2000 Mar; 268(2):482-92. PubMed ID: 10704356
[TBL] [Abstract][Full Text] [Related]
18. Equine herpesvirus type 1 modified live virus vaccines: quo vaditis?
Rosas CT; Goodman LB; von Einem J; Osterrieder N
Expert Rev Vaccines; 2006 Feb; 5(1):119-31. PubMed ID: 16451114
[TBL] [Abstract][Full Text] [Related]
19. The pathogenesis of equine herpesvirus type 1 in the mouse: a new model for studying host responses to the infection.
Awan AR; Chong YC; Field HJ
J Gen Virol; 1990 May; 71 ( Pt 5)():1131-40. PubMed ID: 2161048
[TBL] [Abstract][Full Text] [Related]
20. Cytokine profiles and long-term virus-specific antibodies following immunization of CBA mice with equine herpesvirus 1 and viral glycoprotein D.
Zhang Y; Smith PM; Frampton AR; Osterrieder N; Jennings SR; O'Callaghan DJ
Viral Immunol; 2003; 16(3):307-20. PubMed ID: 14583146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
